Up to 8-fold higher levels of IL-17A and 5-fold higher levels of IL-22 are seen in the serum of patients with autoimmune diseases such as rheumatoid arthritis [5,6], while a 3-fold increase in serum levels of IL-23 has been reported in patients with multiple sclerosis [7]. Here, IL17A is linked to autoimmune disease.